Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Perrigo Navigates Earnings Storm Weathering Change At Helm

This article was originally published in The Tan Sheet

Executive Summary

The OTC private label giant promotes John Hendrickson from president to CEO after Joseph Papa resigns to take the same post at beleaguered specialty pharma Valeant Pharmaceutical International. A lower earnings forecast combined with the leadership change sent Perrigo's share price down 18.09%.

Advertisement

Related Content

Perrigo's Return To OTC Roots Restoring Investor Confidence
Perrigo Trims Workforce, Ships Tysabri License, Stays European Course
Perrigo Wants Answers From Former Owner Of Its Branded Consumer Business
Perrigo Hopes Esomeprazole Helps Make Private Label OTCs A Bright Spot
Perrigo Shareholder Lawsuits Claim Joining Mylan Was A Better Idea

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

PS108301

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel